Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

4 Reasons for Bank ETFs to Win in 2021

Published 01/11/2021, 02:30 AM
Updated 07/09/2023, 06:31 AM

Bank stocks have been recovering fast lately from the pandemic-related slump. SPDR S&P Bank ETF KBE, which lost 3% past year, added 37.1% in the past three months on COVID-19 vaccine news. Notably, Pfizer PFE, Moderna (NASDAQ:MRNA) MRNA and AstraZeneca (NASDAQ:AZN) AZN have come up with back-to-back upbeat vaccine updates since November.

This instigated sooner-than-expected return to economic normalcy and boosted risk-on sentiments, which in turn resulted in a steepening yield curve. Since banks’ net interest margin benefit from a rising rate environment, their stocks have soared lately.

Against this backdrop, below we highlight a few more reasons why banks could be great picks in 2021.

Cheaper Valuation

Banking stocks were beaten down in the peak of the pandemic as fears of higher defaults at the household and corporate levels hit the space hard due to economic slowdown. So, banking stocks are offering value now and have found room for growth (read: ETFs to Play as Vaccine News Looks to Outdo Virus Fear).

Fed’s Signal for Buybacks

The Federal Reserve okayed the resumption of stock buybacks from January, with as much as $11 billion going toward shareholders. This clearly signals banks’ healthy financial position. Results from the central bank’s special coronavirus stress tests showed “a pass for all of the tested banks and a welcomed green light for capital returns,” Susan Roth Katzke, an analyst at Credit Suisse (SIX:CSGN) Group AG, wrote in a note to clients, as quoted on Bloomberg.

It means that the banks have enough capital to counter another wave of virus spread, if there is any. Notably, in June, the Fed put provisional caps on buying back own stocks or increasing dividend payments by the big banks. Soon after the announcement, J.P. Morgan (JPM) announced its $30 billion buyback decision.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Democrats’ Control Over Senate

Analysts believe that a Democratic majority in the Senate would cause an easy passage of President-elect Joe Biden’s agendas as indicated on Street.com. Democrats are apparently in favor of more fiscal stimulus amid the pandemic. We may see $2,000-stimulus checks reaching to Americans. “Things like extended unemployment benefits, postponed (or even forgiven) student loan payments, and small business aid” will likely face less hindrance in getting passed. More stimulus means more economic activity, loan growth and a rising rate environment — all of which a great for banks.

Solid Spike in Bond Yields

Vaccine rollout will result in U.S. normalization this year. This in turn promotes risk-on sentiments and economic growth, helping long-term treasury yields to soar. As of Jan 8, 2021, benchmark treasury yields were 1.13% versus 0.93% at the start of the month and as low as 0.55% recorded in mid-2020. In the coming days, we expect a faster rise in bond yields. With the Fed remaining dovish, such a spike in long-term rates should result in a steepening yield curve. And bank stocks should return to good health.

ETFs in Focus

Against this backdrop, one can bet on bank ETFs like SPDR S&P Bank ETF KBE, Invesco KBW Bank ETF KBWB, iShares U.S. Regional Banks ETF IAT, First Trust NASDAQ ABA Community Bank Index (QABA) and First Trust Nasdaq Bank ETF FTXO. All these bank stocks have a P/E ratios of 12.93X, 12.42X, 11.47X, 14.09X and 14.76X, respectively, way lower than SPDR S&P 500 ETF (SPY)’s P/E of 23.79X. Such undervaluation will help in driving the funds even higher.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

AstraZeneca PLC (AZN): Free Stock Analysis Report

Pfizer Inc. (NYSE:PFE): Free Stock Analysis Report

Moderna, Inc. (MRNA): Free Stock Analysis Report

SPDR S&P Bank ETF (KBE): ETF Research Reports

iShares U.S. Regional Banks ETF (IAT): ETF Research Reports

First Trust NASDAQ Bank ETF (FTXO): ETF Research Reports

Invesco KBW Bank ETF (KBWB): ETF Research Reports

To read this article on Zacks.com click here.

Zacks Investment Research

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.